We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 4 januari 2018

Oncogene - Table of Contents alert Volume 37 Issue 1

If you are unable to see the message below, click here to view.

Volume 37, Issue 1 (January 2018)

In this issue
Original Articles
Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed


Role of SMAD proteins in colitis-associated cancer: from known to the unknown

P Chandrasinghe, B Cereser, M Moorghen, I Al Bakir, N Tabassum et al.

Oncogene 2017 37: 1 - 7; September 04, 2017; 10.1038/onc.2017.300


Abstract | Full Text

Original Articles

RCC2 is a novel p53 target in suppressing metastasis

C Song, L Liang, Y Jin, Y Li, Y Liu et al.

Oncogene 2017 37: 8 - 17; September 04, 2017; 10.1038/onc.2017.306


Abstract | Full Text

Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice

Z Wang, Y He, W Deng, L Lang, H Yang et al.

Oncogene 2017 37: 18 - 27; September 04, 2017; 10.1038/onc.2017.310


Abstract | Full Text

C-reactive protein binds to integrin a2 and Fc? receptor I, leading to breast cell adhesion and breast cancer progression

E-S Kim, S Y Kim, M Koh, H-M Lee, K Kim et al.

Oncogene 2017 37: 28 - 38; August 28, 2017; 10.1038/onc.2017.298


Abstract | Full Text

Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells

K Diehl, L-A Dinges, O Helm, N Ammar, D Plundrich et al.

Oncogene 2017 37: 39 - 51; August 28, 2017; 10.1038/onc.2017.299


Abstract | Full Text

Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2


Oncogene 2017 37: 52 - 62; September 04, 2017; 10.1038/onc.2017.304


Abstract | Full Text

Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment

M R Heerma van Voss, F Vesuna, G M Bol, J Afzal, S Tantravedi et al.

Oncogene 2017 37: 63 - 74; September 04, 2017; 10.1038/onc.2017.308


Abstract | Full Text

Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs

D D H Tran, C Kessler, S E Niehus, M Mahnkopf, A Koch et al.

Oncogene 2017 37: 75 - 85; September 04, 2017; 10.1038/onc.2017.312


Abstract | Full Text

MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression

L Liu, C Luo, Y Luo, L Chen, Y Liu et al.

Oncogene 2017 37: 86 - 94; September 04, 2017; 10.1038/onc.2017.314


Abstract | Full Text

A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo

D F Comiskey Jr, A G Jacob, B L Sanford, M Montes, A K Goodwin et al.

Oncogene 2017 37: 95 - 106; September 11, 2017; 10.1038/onc.2017.282


Abstract | Full Text

MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML

N S D Larmonie, T C J M Arentsen-Peters, A Obulkasim, D Valerio, E Sonneveld et al.

Oncogene 2017 37: 107 - 115; September 11, 2017; 10.1038/onc.2017.293


Abstract | Full Text

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation

W-F Chiang, T-M Cheng, C-C Chang, S-H Pan, C A Changou et al.

Oncogene 2017 37: 116 - 127; September 11, 2017; 10.1038/onc.2017.303


Abstract | Full Text

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A

Q Tu, J Hao, X Zhou, L Yan, H Dai et al.

Oncogene 2017 37: 128 - 138; September 11, 2017; 10.1038/onc.2017.316


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature